CCCarlos J. Cruz

Carlos J. Cruz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carlos J. Cruz has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A single intra-articular injection of IDO-Gal3 shifts synovial fluid metabolic profiles for up to six weeks in male rats with knee instability

    by Folly M. Patterson, Carlos J. Cruz, Brittany D. Partain, Hope Welhaven, Estefania Urrego Hernández, Austen Breland, Jacob L. Griffith, Arun Wanchoo, Jonathan O. Cooper, Joshua F. Yarrow, et al.


  • Associations of Arterial Blood Pressure With Radiographic Knee Osteoarthritis and Pain Sensitivity in Middle‐Aged and Older Adults

    by Carlos J. Cruz, Javier A. Tamargo, Muhammad Abbas, Ruth E. Quintana, Roland Staud, Burel R. Goodin, Roger B. Fillingim, Yenisel Cruz‐Almeida

    Objective: High blood pressure (BP) often co‐occurs with osteoarthritis (OA) and may influence pain sensitivity, potentially contributing to pain‐pathology discordance. We hypothesized that higher BP would associate with reduced pain sensitivity and greater OA severity in adults with chronic knee pain. Methods: A cross‐sectional analysis of 213 community‐dwelling adults (44–78 years) with chronic knee pain was conducted. Hypertension was defined by diagnosis or antihypertensive use; others were normotensive. Systolic, diastolic, pulse (PP), and mean arterial (MAP) BP were measured. Quantitative sensory testing assessed pressure/thermal pain sensitivity, temporal summation (TS), and conditioned pain modulation (CPM). Radiographic knee OA (rKOA) was graded using the Kellgren‐Lawrence scale. Models adjusted for race, age, BMI, site, and diabetes. Results: Blood pressure‐pain associations were moderated by sex and hypertensive status, observed only in normotensive individuals. Among normotensive males, each 10 mmHg increase in BP was associated with reduced pressure pain sensitivity ( β [95% CI]: systolic −0.21 [−0.42, −0.002]; diastolic −0.36 [−0.68, −0.05]; MAP −0.31 [−0.59, −0.03]; all p < 0.05) but greater odds of late‐stage rKOA (AOR [95% CI]: systolic 1.70 [1.07, 2.70]; MAP 2.10 [1.10, 4.01]). Among normotensive females, temporal summation of mechanical pain increased with higher BP ( β [95% CI]: systolic 0.14 [0.01, 0.27], p = 0.027; PP 0.20 [0.02, 0.38], p = 0.026). No significant associations were observed for heat/cold pain sensitivity, TS of heat pain, or CPM. Discussion: Elevated BP was associated with hypoalgesia and more severe rKOA severity in normotensive males. In normotensive females, elevated BP showed greater pain facilitation but not rKOA severity. Together, these sex‐specific findings suggest BP as a vascular factor contributing to pain‐pathology mismatch in OA. Significance Statement: Associations between arterial blood pressure and pain in older adults with knee pain were found to be sex‐ and hypertension‐dependent, primarily evident in normotensive individuals. Elevated blood pressure was associated with reduced mechanical pain sensitivity but greater radiographic OA in normotensive males; normotensive females showed enhanced pain facilitation without increased OA severity. These findings support arterial pressure as a shared vascular factor in pain–pathology mismatch and highlight the importance of incorporating cardiovascular markers into chronic pain phenotyping and interpretation.


  • Open Access

    Circulating cellular senescence biomarkers in persons with chronic knee osteoarthritis pain: An exploratory study

    by Muhammad Abbas, Javier A Tamargo, Carlos J Cruz, Yutao Zhang, Stephanie Wohlgemuth, Kevin Wu, Li Chen, Roland Staud, Roger B Fillingim, Christiaan Leeuwenburgh, et al.

    The senescence-associated secretory phenotype (SASP) contributes to tissue degeneration and inflammation, yet its role in osteoarthritis (OA)-related pain remains poorly understood. We hypothesized that circulating SASP markers would be associated with distinct OA-pain phenotypes, defined by pain impact and radiographic OA (ROA) severity. A subset of middle-to-older-aged adults (45–85 years) from a larger multi-site study ( n = 169) self-reported pain impact – defined as the extent to which pain interferes with daily functioning – and underwent knee radiography and blood collection. Hierarchical cluster analysis was used to empirically identify OA-pain phenotypes based on combined pain impact and Kellgren-Lawrence (KL) grade. Plasma levels of four SASP markers (GDF-15, activin-A, Osteopontin (OPN), and IL-15) were quantified from whole blood samples. Among 169 participants, 35.5% reported high-impact chronic knee pain and 27.8% exhibited moderate-to-severe radiographic OA. Cluster analysis identified distinct ROA-pain phenotypes. GDF-15 levels were significantly elevated in non-Hispanic White females with early ROA and high-impact pain, with race- and sex-dependent differences. Activin-A levels were higher in non-Hispanic Black participants without pain or ROA and varied by sex in early ROA/low-impact pain phenotypes. Osteopontin levels were elevated in males compared to females within the same phenotype group. IL-15 levels showed no association with ROA-pain phenotypes but were higher in males and positively correlated with age. SASP factors, particularly GDF-15, Activin-A, and Osteopontin, demonstrated race- and sex-dependent associations with OA-pain phenotypes. These findings underscore the importance of demographic context in OA pathophysiology and support further investigation into SASP factors as potential biomarkers and therapeutic targets for OA-related pain.


  • Pipeline Validation for Rodent Gait Analysis Using deeplabcut

    by L. Savannah Dewberry, Carlos J. Cruz, Kaitlin M. Southern, Kevin J. Otto, Kyle D. Allen

    This study aimed to integrate deeplabcut (dlc) with our Automatic Gait Analysis Through Hues and Areas (AGATHA) algorithm. Prior work with AGATHA shows that it can be used to understand spatiotemporal gait adaptations in multiple disease models. However, AGATHA cannot detect kinematic variables, like joint angles, which dlc was designed to measure. Here, these two approaches are integrated, and the gait variables that can be achieved with both methods are compared. To train dlc, hand digitization of high-speed videos was conducted to estimate the location of several key anatomical markers; then a neural network within dlc was used to automate the digitization of these same points in subsequent videos. A matlab pipeline was developed to calculate average stride profiles for toe height, back angle, and midfoot angle from dlc coordinates. Then, 418 videos of naïve Sprague-Dawley rats (12 w.o., n = 18) walking unprompted across an arena were collected. These videos were analyzed using dlc and AGATHA. For velocity, hind limb duty factor, stride length, and step width, variability was larger in dlc than in AGATHA. However, when used in conjunction, dlc and AGATHA have strong complementary datasets, where AGATHA can provide spatiotemporal and dynamic measures, and dlc can provide kinematic measures that AGATHA cannot currently measure. Decisions on whether to use AGATHA alone, dlc alone, or AGATHA–dlc in tandem are thus dependent on the gait variables being evaluated.

  • Open Access

    Comorbid hypertension and osteoarthritis exacerbates joint remodeling and gait compensations in female rats with milder effects observed in males

    by Carlos J. Cruz, Folly M. Patterson, Janak Gaire, Julianna Gonzalez, Jacob L. Griffith, Angela Philistin, Kyle D. Allen


  • Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis

    by Carlos J. Cruz, L. Savannah Dewberry, Kevin J. Otto, Kyle D. Allen

    Purpose of Review The following review discusses the therapeutic potential of targeting the autonomic nervous system (ANS) for osteoarthritis (OA) treatment and encourages the field to consider the candidacy of bioelectronic medicine as a novel OA treatment strategy. Recent Findings The study of OA pathogenesis has focused on changes occurring at the joint level. As such, treatments for OA have been aimed at the local joint environment, intending to resolve local inflammation and decrease pain. However, OA pathogenesis has shown to be more than joint wear and tear. Specifically, OA-related peripheral and central sensitization can prompt neuroplastic changes in the nervous system beyond the articular joint. These neuroplastic changes may alter physiologic systems, like the neuroimmune axis. In this way, OA and related comorbidities may share roots in the form of altered neuroimmune communication and autonomic dysfunction. Summary ANS modulation may be able to modify OA pathogenesis or reduce the impact of OA comorbidities. Moreover, blocking chronic nociceptive drive from the joint may help to prevent maladaptive nervous system plasticity in OA.